YOLFTbeta
Pharmena S.A.

Pharmena S.A.

PHR · WAR · Healthcare / Biotechnology

2.81PLN+0.07 (+2.55%)

Price History

Full chart

Market Stats

Previous Close2.74
Open2.84
Day Range2.70 – 2.84
52-Week Range2.50 – 4.32
Volume1.42K
Market Cap34.08M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.27
Dividend Yield72.39%
Beta0.50
50-Day Avg3.13
200-Day Avg3.27

About

Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. The company also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, it is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. The company was incorporated in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Konrad Palka
  • Employees7
  • Headquartersul. Gdanska 47/49, Lódz, Poland, 90-729, Poland
  • Websitehttps://www.pharmena.eu

Leadership

  • Mr. Konrad PalkaPresident of Management Board, CEO & President
  • Ms. Marzena WieczorkowskaVP of the Management Board and VP of Research & Development

Financials

Income Statement

Currency: PLN2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.81M6.38M7.70M8.78M9.13M14.14M14.13M17.47M15.91M12.51M13.04M11.10M9.93M15.21M299.00K9.84M268.00K1.58M
Growth (%)-+67.45%+20.77%+13.94%+4.01%+54.85%-0.06%+23.67%-8.92%-21.38%+4.23%-14.88%-10.51%+53.16%-98.03%+3189.97%-97.28%+488.43%
Cost of Revenue1.46M2.02M5.03M5.31M2.84M4.11M4.06M4.85M4.41M3.57M4.23M3.70M4.85M7.38M8.69M3.99M70.00K388.00K
Gross Profit2.35M4.36M2.67M3.47M6.29M10.03M10.07M12.62M11.50M8.94M8.81M7.40M5.08M7.83M10.34M5.84M198.00K1.19M
Gross Margin61.58%68.38%34.72%39.51%68.92%70.94%71.24%72.23%72.29%71.44%67.58%66.67%51.19%51.48%3456.52%59.40%73.88%75.40%
Operating Expense2.05M3.84M2.74M2.77M9.30M11.37M13.85M15.46M12.65M10.97M8.73M17.64M11.12M11.81M10.84M-29.03M3.60M4.47M
Operating Income300.63K524.64K-66.98K694.89K-3.01M-1.34M-3.79M-2.84M-1.14M-2.03M83.00K-10.24M-6.04M-3.98M-508.00K34.87M-3.40M-3.28M
Operating Margin7.89%8.22%-0.87%7.92%-33.00%-9.51%-26.79%-16.26%-7.18%-16.24%0.64%-92.30%-60.76%-26.18%-169.90%354.49%-1267.54%-208.05%
EBITDA956.69K648.95K52.99K885.86K-3.03M-2.17M-3.25M-2.65M-819.00K-1.87M410.00K-9.65M-5.40M-3.52M-129.00K35.55M-3.38M-3.16M
EBITDA Margin25.11%10.17%0.69%10.09%-33.18%-15.36%-22.97%-15.18%-5.15%-14.95%3.14%-86.94%-54.36%-23.11%-43.14%361.41%-1261.94%-200.19%
Net Income611.36K771.54K123.73K609.00K-4.10M-2.84M-4.09M-3.62M-1.66M-2.39M-444.00K-9.57M-6.89M-4.59M-1.57M28.94M-1.26M-2.77M
Net Income Margin16.05%12.09%1.61%6.94%-44.91%-20.11%-28.92%-20.69%-10.46%-19.10%-3.40%-86.25%-69.37%-30.18%-525.08%294.21%-470.90%-175.59%
R&D-----------98.00K-133.00K153.00K-10.00K-
R&D as % of Total Revenue-----------0.88%-0.87%51.17%-3.73%-
Interest Expense18.56K38.07K256.68K67.36K209.00K523.00K26.00K79.00K127.00K191.00K181.00K387.00K204.00K265.00K722.00K530.00K38.00K20.00K
Interest Expense % of Total Revenue0.49%0.60%3.33%0.77%2.29%3.70%0.18%0.45%0.80%1.53%1.39%3.49%2.05%1.74%241.47%5.39%14.18%1.27%

Balance Sheet

Currency: PLN2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets16.52M17.09M16.82M18.05M11.59M20.56M16.86M15.16M14.28M11.10M6.80M11.74M10.95M11.15M12.58M24.13M13.53M10.92M
Total Liabilities735.26K934.89K912.97K1.60M2.61M2.51M3.78M6.49M8.34M7.54M4.87M6.74M11.30M16.27M19.37M1.91M1.11M1.27M
Total Equity15.78M16.16M15.91M16.45M8.98M18.05M13.08M8.67M5.94M3.56M1.94M5.14M-139.00K-4.87M-6.49M22.52M12.42M9.65M
Cash11.72M8.76M--3.20M11.15M5.22M2.79M815.00K221.00K469.00K1.05M1.72M1.46M1.59M22.24M1.75M357.00K
Total Debt582.49----17.00K1.02M4.10M4.41M3.63M1.07M489.00K5.51M9.71M10.14M183.00K244.00K366.00K
Net Debt-11.71M-8.76M---3.20M-11.14M-4.20M1.31M3.60M3.41M597.00K-559.00K-1.33M-678.00K-1.08M-22.06M-1.50M9.00K

Cash Flow

Currency: PLN2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-32.56K-179.22K-1.08M666.91K-4.05M-3.84M-5.75M-4.17M-950.00K619.00K3.61M-13.15M-2.24M-3.23M1.82M33.03M-2.53M-2.73M
Investing Cash Flow-1.28M-2.35M-3.97M-1.34M-220.00K-12.00K-93.00K-96.00K-124.00K-197.00K-446.00K-273.00K-198.00K-248.00K-219.00K-3.13M-8.36M1.42M
Financing Cash Flow12.91M-423.88K-404.11K-85.42K4.48M11.80M-87.00K1.84M-899.00K-1.02M-2.92M14.00M3.12M3.21M-1.47M-9.26M-9.54M-79.00K
Capital Expenditure4.51K49.85K8.49K68.89K233.00K12.00K110.00K133.00K124.00K197.00K446.00K273.00K214.00K319.00K226.00K314.00K180.00K237.00K
Free Cash Flow-37.07K-229.07K-1.09M598.01K-4.29M-3.85M-5.86M-4.31M-1.07M422.00K3.17M-13.42M-2.46M-3.54M1.59M32.72M-2.71M-2.96M
Dividends Paid-375.26K375.26K62.54K313.00K880.00K967.00K967.00K1.05M-------9.47M-
FCF to OCF113.86%127.82%100.79%89.67%105.75%100.31%101.91%103.19%113.05%68.17%87.66%102.08%109.54%109.89%87.58%99.05%107.11%108.70%
Dividend Paid to FCF--163.82%-34.44%10.46%-7.30%-22.87%-16.50%-22.45%-98.23%--------349.21%-

Earnings

Report DateMar 31, 2009Dec 31, 2009Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Aug 14, 2014Nov 14, 2014Feb 13, 2015Apr 29, 2015Aug 14, 2015Nov 13, 2015Feb 12, 2016May 13, 2016Aug 12, 2016Nov 14, 2016Feb 10, 2017May 8, 2017Aug 11, 2017Nov 13, 2017Mar 21, 2018May 14, 2018Aug 13, 2018Nov 13, 2018Mar 21, 2019May 30, 2019Sep 30, 2019Nov 14, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Nov 25, 2022Dec 31, 2022May 26, 2023Nov 27, 2023Feb 29, 2024May 27, 2024Aug 26, 2024Nov 25, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Mar 30, 2026Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------
EPS Actual0.06-0.02-0.06-0.09-0.04-0.12-0.17-0.11-0.03-0.15-0.07-0.08-0.01-0.23-0.15-0.020.00-0.01-0.07-0.10-0.04-0.060.07-0.01-0.00-0.11-0.06-0.50-0.10-0.21-0.15-0.07-0.32-0.05-0.17-0.05-0.14-0.02-0.04-0.01-0.07-0.012.71-0.040.02-0.08-0.04-0.01-0.04-0.06-0.06-0.08-0.04-0.09
Surprise------------------------------------------------------
Timing-------Pre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---------After-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours----Pre-market--

Key Statistics & Ratios

Market Cap34.08M
Enterprise Value28.91M
Trailing P/E0.00
Forward P/E0.00
Price / Sales23.33
Price / Book4.23
EPS-0.27
Book Value0.734
Revenue (TTM)1.46M
Gross Profit (TTM)1.20M
EBITDA-3.30M
Profit Margin-209.24%
Operating Margin-433.88%
Return on Equity-31.51%
Return on Assets-19.22%
Shares Outstanding11.14M
Shares Float3.31M
Beta0.50
Dividend Yield72.39%
Dividend Rate2.36
Payout Ratio0.00%

Dividends

20241×
0.85Apr 9, 2024
20161×
0.11Aug 3, 2016
20151×
0.11Jun 30, 2015
20141×
0.11Jun 27, 2014
20131×
0.10Aug 28, 2013
20121×
0.04Jun 12, 2012
20111×
0.01Jun 23, 2011
20101×
0.05Aug 2, 2010
20091×
0.05Jun 29, 2009

Stock Splits

  • Dec 19, 2018757:723
  • Jun 5, 2013445:431
  • Sep 4, 20121467:1369